102 related articles for article (PubMed ID: 30521940)
21. Cx43 Mediates Resistance against MPP⁺-Induced Apoptosis in SH-SY5Y Neuroblastoma Cells via Modulating the Mitochondrial Apoptosis Pathway.
Kim IS; Ganesan P; Choi DK
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27809287
[TBL] [Abstract][Full Text] [Related]
22. Salidroside protects against MPP(+)-induced apoptosis in PC12 cells by inhibiting the NO pathway.
Li X; Ye X; Li X; Sun X; Liang Q; Tao L; Kang X; Chen J
Brain Res; 2011 Mar; 1382():9-18. PubMed ID: 21241673
[TBL] [Abstract][Full Text] [Related]
23. Role of c-Abl-GSK3β Signaling in MPP+-Induced Autophagy-Lysosomal Dysfunction.
Ren Y; Chen J; Wu X; Gui C; Mao K; Zou F; Li W
Toxicol Sci; 2018 Sep; 165(1):232-243. PubMed ID: 30165626
[TBL] [Abstract][Full Text] [Related]
24. SKF-96365 attenuates toxin-induced neuronal injury through opposite regulatory effects on Homer1a and Homer1b/c in cultured rat mesencephalic cells.
Zeng X; Pan ZG; Shao Y; Wu XN; Liu SX; Li NL; Wang WM
Neurosci Lett; 2013 May; 543():183-8. PubMed ID: 23567742
[TBL] [Abstract][Full Text] [Related]
25. Involvement of metabotropic glutamate receptor 5 in cardiomyocyte differentiation from mouse embryonic stem cells.
Zhu DY; Zhou LM; Zhang YY; Huang JQ; Pan X; Lou YJ
Stem Cells Dev; 2012 Aug; 21(12):2130-41. PubMed ID: 22188633
[TBL] [Abstract][Full Text] [Related]
26. [Role of calcium dyshomeostasis in 1-methyl-4-phenylpyridinium ion-induced apoptosis of human neuroblastoma SH-SY5Y cells].
Xu L; Li W; Lin D; Zhang H; Zou F
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):479-85. PubMed ID: 23644103
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of NogoA prevents MPP+‑induced neurotoxicity in PC12 cells via the mTOR/STAT3 signaling pathway.
Zhong J; Li X; Wan L; Chen Z; Zhong S; Xiao S; Yan Z
Mol Med Rep; 2016 Feb; 13(2):1427-33. PubMed ID: 26648565
[TBL] [Abstract][Full Text] [Related]
29. PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson's Disease.
Luo WY; Xing SQ; Zhu P; Zhang CG; Yang HM; Van Halm-Lutterodt N; Gu L; Zhang H
Neurotherapeutics; 2019 Jul; 16(3):761-783. PubMed ID: 31073978
[TBL] [Abstract][Full Text] [Related]
30. UNC-51-like kinase 1 blocks S6k1 phosphorylation contributes to neurodegeneration in Parkinson's disease model in vitro.
Li Y; Zhang J; Yang C
Biochem Biophys Res Commun; 2015 Apr; 459(2):196-200. PubMed ID: 25680463
[TBL] [Abstract][Full Text] [Related]
31. 1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum.
Nakai M; Mori A; Watanabe A; Mitsumoto Y
Exp Neurol; 2003 Jan; 179(1):103-10. PubMed ID: 12504872
[TBL] [Abstract][Full Text] [Related]
32. Orchestrated activation of mGluR5 and CB1 promotes neuroprotection.
Batista EM; Doria JG; Ferreira-Vieira TH; Alves-Silva J; Ferguson SS; Moreira FA; Ribeiro FM
Mol Brain; 2016 Aug; 9(1):80. PubMed ID: 27543109
[TBL] [Abstract][Full Text] [Related]
33. Ablation of Shank1 Protects against 6-OHDA-induced Cytotoxicity via PRDX3-mediated Inhibition of ER Stress in SN4741 Cells.
Xu YP; Zhang J; Mei X; Wu Y; Jiao W; Wang YH; Zhang AQ
CNS Neurol Disord Drug Targets; 2024; 23(3):402-410. PubMed ID: 36797610
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
[TBL] [Abstract][Full Text] [Related]
35. Metabotropic glutamate receptor 5 mediates the suppressive effect of 6-OHDA-induced model of Parkinson's disease on liver cancer.
Xi SS; Bai XX; Gu L; Bao LH; Yang HM; An W; Wang XM; Zhang H
Pharmacol Res; 2017 Jul; 121():145-157. PubMed ID: 28455267
[TBL] [Abstract][Full Text] [Related]
36. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1.
Yang HJ; Wang L; Xia YY; Chang PN; Feng ZW
Neurochem Int; 2010 Jan; 56(1):128-34. PubMed ID: 19778565
[TBL] [Abstract][Full Text] [Related]
37. MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
Li W; Jiang Y; Wang Y; Yang S; Bi X; Pan X; Ma A; Li W
Neurosci Lett; 2018 May; 675():83-88. PubMed ID: 29608948
[TBL] [Abstract][Full Text] [Related]
38. Isorhynchophylline Attenuates MPP
Li XM; Zhang XJ; Dong MX
Neuromolecular Med; 2017 Dec; 19(4):480-492. PubMed ID: 28822073
[TBL] [Abstract][Full Text] [Related]
39. Involvement of nitric oxide/reactive oxygen species signaling via 8-nitro-cGMP formation in 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells and rat cerebellar granule neurons.
Masuda K; Tsutsuki H; Kasamatsu S; Ida T; Takata T; Sugiura K; Nishida M; Watanabe Y; Sawa T; Akaike T; Ihara H
Biochem Biophys Res Commun; 2018 Jan; 495(3):2165-2170. PubMed ID: 29258821
[TBL] [Abstract][Full Text] [Related]
40. Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model.
Sawada H; Ibi M; Kihara T; Honda K; Nakamizo T; Kanki R; Nakanishi M; Sakka N; Akaike A; Shimohama S
Neuropharmacology; 2002 Jun; 42(8):1056-64. PubMed ID: 12128007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
